Concepedia

Raphaëlle El Habib

RE

Statistics

Publications

24

Citations

1.8K

H-Index

20

Active since

1991

Affiliations

Inserm(Current)

Sanofi (France)

Duke Medical Center

Institut Mérieux (France)

University of Alabama at Birmingham

Raphaëlle El Habib is an author at Inserm specializing in immunology, infectious diseases, and life sciences.

Publications per year

1991–2014

24

Publications

24

Immunization with Recombinant Canarypox Vectors Expressing Membrane-Anchored Glycoprotein 120 Followed by Glycoprotein 160 Boosting Fails to Generate Antibodies That Neutralize R5 Primary Isolates of Human Immunodeficiency Virus Type 1

Renata Bures, Alicia Gaitan, Tuofu Zhu et al. · AIDS Research and Human Retroviruses · 2000 · 147 citations

, , +17

Safety and Immunogenicity of a Canarypox‐Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher‐ and Lower‐Risk Volunteers

Robert B. Belshe, Cladd E. Stevens, Geoffrey J. Gorse et al. · The Journal of Infectious Diseases · 2001 · 145 citations · Full text

, , +17

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Mark de Souza, Silvia Ratto‐Kim, Weerawan Chuenarom et al. · The Journal of Immunology · 2012 · 140 citations · Full text

, , +17

Safety and Immunogenicity of an HIV Subtype B and E Prime‐Boost Vaccine Combination in HIV‐Negative Thai Adults

Sorachai Nitayaphan, Punnee Pitisuttithum, Chitraporn Karnasuta et al. · The Journal of Infectious Diseases · 2004 · 139 citations · Full text

, , +17

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein

Eliane Coëffier, Jean-Marie Clément, V Cussac et al. · Vaccine · 2000 · 123 citations

, , +12

1–5 of 24